Loading company…
Stellanova Therapeutics develops targeted cancer therapies and holds interests in biopharma companies.
Founded in 2019 and based in Houston, US, Stellanova Therapeutics focuses on cancer therapies and has equity interests in Tvardi Therapeutics and Asylia Therapeutics. It raised USD 15.5 mn in Series A funding led by Sporos Bioventures on June 3, 2021, to advance an antibody asset toward clinical trials and build its discovery platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in